Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

1.

Adalimumab therapy for refractory childhood uveitis.

Bravo-Ljubetic L, Peralta-Calvo J, Noval S, Pastora-Salvador N, Abelairas-Gómez J, Merino R.

J AAPOS. 2013 Oct;17(5):456-9. doi: 10.1016/j.jaapos.2013.06.009. Erratum in: J AAPOS. 2013 Dec;17(6):654. Merino, Rosa [added].

PMID:
24160962
[PubMed - indexed for MEDLINE]
2.

Blau syndrome-associated uveitis and the NOD2 gene.

Pillai P, Sobrin L.

Semin Ophthalmol. 2013 Sep-Nov;28(5-6):327-32. doi: 10.3109/08820538.2013.825285. Epub 2013 Sep 6. Review.

PMID:
24010719
[PubMed - indexed for MEDLINE]
3.

Preferentially inflamed tendon sheaths in the swollen but not tender joints in a 5-year-old boy with Blau syndrome.

Ikeda K, Kambe N, Satoh T, Matsue H, Nakajima H.

J Pediatr. 2013 Nov;163(5):1525.e1. doi: 10.1016/j.jpeds.2013.05.059. Epub 2013 Jul 26. No abstract available.

PMID:
23896186
[PubMed - indexed for MEDLINE]
4.

Autoinflammatory diseases in pediatrics.

Hausmann JS, Dedeoglu F.

Dermatol Clin. 2013 Jul;31(3):481-94. doi: 10.1016/j.det.2013.04.003. Epub 2013 Jun 2. Review.

PMID:
23827250
[PubMed - indexed for MEDLINE]
5.

Retinal vasculitis, aneurysms, and neovascularization in Blau syndrome.

Amin SR, Pulido JS.

JAMA Ophthalmol. 2013 May;131(5):677-80. doi: 10.1001/jamaophthalmol.2013.413a. No abstract available.

PMID:
23699845
[PubMed - indexed for MEDLINE]
6.

Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases.

Yao Q.

Semin Arthritis Rheum. 2013 Aug;43(1):125-30. doi: 10.1016/j.semarthrit.2012.12.005. Epub 2013 Jan 24. Review.

PMID:
23352252
[PubMed - indexed for MEDLINE]
7.

A genome-wide siRNA screen reveals positive and negative regulators of the NOD2 and NF-κB signaling pathways.

Warner N, Burberry A, Franchi L, Kim YG, McDonald C, Sartor MA, Núñez G.

Sci Signal. 2013 Jan 15;6(258):rs3. doi: 10.1126/scisignal.2003305.

PMID:
23322906
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Immunohistochemical evidence of specific iris involvement in Blau syndrome.

Paparizos SC, Goldstein DA, Bouhenni RA, Steiner S, Dunmire JJ, Edward DP.

Ocul Immunol Inflamm. 2012 Dec;20(6):471-4. doi: 10.3109/09273948.2012.726391.

PMID:
23215732
[PubMed - indexed for MEDLINE]
9.

Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis.

Simonini G, Xu Z, Caputo R, De Libero C, Pagnini I, Pascual V, Cimaz R.

Arthritis Rheum. 2013 Feb;65(2):513-8. doi: 10.1002/art.37776.

PMID:
23124805
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Ocular manifestations of the autoinflammatory syndromes.

Tarabishy AB, Hise AG, Traboulsi EI.

Ophthalmic Genet. 2012 Dec;33(4):179-86. doi: 10.3109/13816810.2012.695421. Epub 2012 Aug 27. Review.

PMID:
22924780
[PubMed - indexed for MEDLINE]
11.

Blau syndrome, clinical and genetic aspects.

Sfriso P, Caso F, Tognon S, Galozzi P, Gava A, Punzi L.

Autoimmun Rev. 2012 Nov;12(1):44-51. doi: 10.1016/j.autrev.2012.07.028. Epub 2012 Aug 2. Review.

PMID:
22884558
[PubMed - indexed for MEDLINE]
12.

Blau arteritis resembling Takayasu disease with a novel NOD2 mutation.

Khubchandani RP, Hasija R, Touitou I, Khemani C, Wouters CH, Rose CD.

J Rheumatol. 2012 Sep;39(9):1888-92. doi: 10.3899/jrheum.120156. Epub 2012 Aug 1.

PMID:
22859352
[PubMed - indexed for MEDLINE]
13.

The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment.

Grimes CL, Ariyananda Lde Z, Melnyk JE, O'Shea EK.

J Am Chem Soc. 2012 Aug 22;134(33):13535-7. doi: 10.1021/ja303883c. Epub 2012 Aug 13.

PMID:
22857257
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

A case of infantile Takayasu arteritis with a p.D382E NOD2 mutation: an unusual phenotype of Blau syndrome/early-onset sarcoidosis?

Inoue Y, Kawaguchi Y, Shimojo N, Yamaguchi K, Morita Y, Nakano T, Arima T, Tomiita M, Kohno Y.

Mod Rheumatol. 2013 Jul;23(4):837-9. doi: 10.1007/s10165-012-0720-z. Epub 2012 Jul 21.

PMID:
22821420
[PubMed - indexed for MEDLINE]
15.

A case of acute kidney injury with marked hyperuricemia during mizoribine administration.

Nishino T, Shinzato T, Ohta Y, Yamashita H, Obata Y, Shinzato K, Kohno S.

Intern Med. 2012;51(10):1239-43. Epub 2012 May 15.

PMID:
22687797
[PubMed - indexed for MEDLINE]
Free Article
16.

Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP.

Mo J, Boyle JP, Howard CB, Monie TP, Davis BK, Duncan JA.

J Biol Chem. 2012 Jun 29;287(27):23057-67. doi: 10.1074/jbc.M112.344283. Epub 2012 May 1.

PMID:
22549783
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Ubiquitination and phosphorylation in the regulation of NOD2 signaling and NOD2-mediated disease.

Tigno-Aranjuez JT, Abbott DW.

Biochim Biophys Acta. 2012 Nov;1823(11):2022-8. doi: 10.1016/j.bbamcr.2012.03.017. Epub 2012 Apr 11. Review.

PMID:
22522061
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

NOD2/CARD15 gene mutation identified in a Chinese family with Blau syndrome.

Xiang H, Zhang T, Chen M, Zhou X, Li Z, Yan N, Li S, Han Y, Gong Q, Liu X.

Mol Vis. 2012;18:617-23. Epub 2012 Mar 9.

PMID:
22509093
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2-related disorders Blau syndrome and Crohn disease.

Janssen CE, Rose CD, De Hertogh G, Martin TM, Bader Meunier B, Cimaz R, Harjacek M, Quartier P, Ten Cate R, Thomee C, Desmet VJ, Fischer A, Roskams T, Wouters CH.

J Allergy Clin Immunol. 2012 Apr;129(4):1076-84. doi: 10.1016/j.jaci.2012.02.004.

PMID:
22464675
[PubMed - indexed for MEDLINE]
20.

Rare hereditary autoinflammatory disorders: towards an understanding of critical in vivo inflammatory pathways.

Kanazawa N.

J Dermatol Sci. 2012 Jun;66(3):183-9. doi: 10.1016/j.jdermsci.2012.01.004. Epub 2012 Jan 18. Review.

PMID:
22336993
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk